Disposition of 2221 shares by Jacques Rachelle Suzanne of Uniqure NV at 5.14 subject to Rule 16b-3
QURE Stock | USD 14.18 0.93 7.02% |
About 70 percent of all Uniqure NV's shareholders are curious in acquiring. The analysis of the overall investor sentiment regarding Uniqure NV suggests that quite a large number of traders are confidant. The current market sentiment, together with Uniqure NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Uniqure NV stock news signals to limit their universe of possible portfolio assets.
Uniqure |
Filed transaction by Uniqure NV Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Uniqure NV's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Uniqure NV's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Uniqure NV Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Uniqure NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Uniqure NV Fundamental Analysis
We analyze Uniqure NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Uniqure NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Uniqure NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Uniqure NV is currently under evaluation in target price category among its peers.
Uniqure NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Uniqure NV stock to make a market-neutral strategy. Peer analysis of Uniqure NV could also be used in its relative valuation, which is a method of valuing Uniqure NV by comparing valuation metrics with similar companies.
Peers
Uniqure NV Related Equities
AMLX | Amylyx Pharmaceuticals | 3.62 | ||||
RCKT | Rocket Pharmaceuticals | 3.46 | ||||
STRO | Sutro Biopharma | 2.87 | ||||
PHAT | Phathom Pharmaceuticals | 2.67 | ||||
SLDB | Solid Biosciences | 2.28 | ||||
LRMR | Larimar Therapeutics | 2.14 | ||||
XFOR | X4 Pharmaceuticals | 2.00 | ||||
MGTX | MeiraGTx Holdings | 1.52 | ||||
INZY | Inozyme Pharma | 1.48 | ||||
KNSA | Kiniksa Pharmaceuticals | 0.46 | ||||
DAWN | Day One | 0.41 | ||||
PCVX | Vaxcyte | 0.19 | ||||
GPCR | Structure Therapeutics | 0.08 | ||||
PTGX | Protagonist Therapeutics | 0.03 | ||||
MRUS | Merus BV | 0.25 | ||||
RGNX | Regenxbio | 0.27 | ||||
TERN | Terns Pharmaceuticals | 0.49 | ||||
ABOS | Acumen Pharmaceuticals | 0.68 | ||||
SNDX | Syndax Pharmaceuticals | 1.06 | ||||
REPL | Replimune | 1.33 | ||||
RYTM | Rhythm Pharmaceuticals | 1.51 | ||||
RNA | Avidity Biosciences | 2.15 |
Complementary Tools for Uniqure Stock analysis
When running Uniqure NV's price analysis, check to measure Uniqure NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Uniqure NV is operating at the current time. Most of Uniqure NV's value examination focuses on studying past and present price action to predict the probability of Uniqure NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Uniqure NV's price. Additionally, you may evaluate how the addition of Uniqure NV to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |